Vivos Therapeutics, Inc. (VVOS) Operating margin 2019–2025
Vivos Therapeutics, Inc. (VVOS) operating margin by fiscal year — reported operating income divided by reported revenue.
-114.1%FY2025 · since FY2019: -92.8% → -114.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -114.1% | -39.7 pp |
| FY2024 | -74.3% | +51.0 pp |
| FY2023 | -125.3% | +30.9 pp |
| FY2022 | -156.2% | -35.5 pp |
| FY2021 | -120.7% | -28.6 pp |
| FY2020 | -92.1% | +0.7 pp |
| FY2019 | -92.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice